Cargando…
Adoption of new drugs by physicians: a survival analysis
BACKGROUND: New drugs often substitute others cheaper and with a risk-benefit balance better established. Our aim was to analyse the diffusion of new drugs during the first months of use, examining the differences between family physicians and specialists. METHODS: Prescription data were obtained of...
Autores principales: | Garjón, Francisco Javier, Azparren, Ana, Vergara, Iván, Azaola, Borja, Loayssa, Jose Ramón |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353238/ https://www.ncbi.nlm.nih.gov/pubmed/22401169 http://dx.doi.org/10.1186/1472-6963-12-56 |
Ejemplares similares
-
Influence of peer networks on physician adoption of new drugs
por: Donohue, Julie M., et al.
Publicado: (2018) -
New Association of Southwest—Form of Organization Adopted by Physicians and Surgeons
Publicado: (1906) -
Patient-reported outcomes in ANCA-associated vasculitis: a cross-sectional study to explore the interactions between patients’ and physicians’ perspectives
por: Hurtado-Arias, José Joel, et al.
Publicado: (2023) -
Association between physician adoption of a new oral anti-diabetic medication and Medicare and Medicaid drug spending
por: Metes, Ilinca D., et al.
Publicado: (2019) -
Association of Physician Peer Influence With Subsequent Physician Adoption and Use of Bevacizumab
por: Keating, Nancy L., et al.
Publicado: (2020)